Feniou, César
Hassan, Muhammad
Claudon, Baptiste
Courtat, Axel
Adjoua, Olivier
Maday, Yvon
Piquemal, Jean-Philip
Funding for this research was provided by:
HORIZON EUROPE European Research Council (810367)
Article History
Received: 7 January 2025
Accepted: 23 April 2025
First Online: 28 May 2025
Declarations
:
: JPP is shareholder and co-founder of Qubit Pharmaceuticals. All the remaining authors declare no conflict of interest.